xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

394

KUANetal.

abdominal CT, positron emission tomography and abdominal ultrasound. Clin Otolaryngol . 2012;37(3):197-206. https://doi. org/10.1111/j.1749-4486.2012.02481.x 427. Spector ME, Chinn SB, Rosko AJ, et al. Diagnostic modal ities for distant metastasis in head and neck squamous cell carcinoma: are we changing life expectancy? Laryn goscope . 2012;122(7):1507-1511. https://doi.org/10.1002/ lary.23264 428. Kim SA, Chung YS, Lee BJ. Recurrence patterns of sinonasal cancers after a 5-year disease-free period. Laryngoscope . 2019;129(11):2451-2457. https://doi.org/10.1002/lary.27866 429. Peacock JG, Harmsen WS, Link MJ, et al. Risk of delayed lymph node metastasis in clinically N0 esthesioneuroblas toma. J Neurol Surg B Skull Base . 2017;78(1):68-74. https://doi. org/10.1055/s-0036-1584904 430. Maina IW, Lehrich BM, Goshtasbi K, et al. Extraprimary local recurrence of esthesioneuroblastoma: case series and litera ture review. World Neurosurg . 2020;144:e546-e552. https://doi. org/10.1016/j.wneu.2020.08.227 431. Workman AD, Velasquez N, Khan NI, et al. Rates of symp tomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi institutional study. Int Forum Allergy Rhinol . 2019;9(6):688 694. https://doi.org/10.1002/alr.22310 432. Mattavelli D, Tomasoni M, Ferrari M, et al. Salvage surgery in recurrent sinonasal cancers: proposal for a prognostic model based on clinicopathologic and treatment-related parameters. HeadNeck . 2022;44(8):1857-1870. https://doi.org/10.1002/hed. 27102 433. Ono T, Sakata K, Tanaka N, et al. Salvage surgery for a locally persistent or recurrent tumour in maxillary cancer patients who have undergone radiotherapy and concomitant intra arterial cisplatin: implications for surgical margin assessment. Int J Oral Maxillofac Surg . 2019;48(5):567-575. https://doi.org/ 10.1016/j.ijom.2018.10.019 434. Tsushima N, Kano S, Suzuki T, et al. Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cis platin infusion with concomitant radiation therapy. Eur Arch Otorhinolaryngol . 2022;279(2):899-905. https://doi.org/ 10.1007/s00405-021-06822-5 435. Orlandi E, Cavalieri S, Granata R, et al. Locally advanced epithelial sinonasal tumors: the impact of multimodal approach. Laryngoscope . 2020;130(4):857-865. https://doi.org/ 10.1002/lary.28202 436. Gore MR, Zanation AM. Salvage treatment of local recur rence in esthesioneuroblastoma: a meta-analysis. Skull Base . 2011;21(1):1-6. https://doi.org/10.1055/s-0030-1254406 437. Gore MR, Zanation AM. Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis. Arch Otolaryngol Head Neck Surg . 2009;135(10):1030-1034. https:// doi.org/10.1001/archoto.2009.143 438. Iwata H, Tatewaki K, Inoue M, Yokota N, Sato K, Shibamoto Y. Salvage stereotactic reirradiation using the CyberKnife for the local recurrence of nasal or paranasal carcinoma. Radiother Oncol . 2012;104(3):355-360. https://doi.org/10.1016/ j.radonc.2012.01.017 439. Gao J, Hu J, Guan X, et al. Salvage carbon-ion radiation therapy for locoregionally recurrent head and neck malignan-

414. Ackall FY, Issa K, Barak I, et al. Survival outcomes in sinonasal poorly differentiated squamous cell carci noma. Laryngoscope . 2021;131(4):E1040-E1048. https://doi. org/10.1002/lary.29090 415. Janecka IP, Sen C, Sekhar L, Curtin H. Treatment of paranasal sinus cancer with cranial base surgery: results. Laryngo scope . 1994;104(5 Pt 1):553-555. https://doi.org/10.1002/lary. 5541040508 416. Thorup C, Sebbesen L, Danø H, et al. Carcinoma of the nasal cavity and paranasal sinuses in Denmark 1995– 2004. ActaOncol . 2010;49(3):389-394. https://doi.org/10.3109/ 02841860903428176 417. Kaplan DJ, Kim JH, Wang E, Snyderman C. Prognostic indi cators for salvage surgery of recurrent sinonasal malignancy. Otolaryngol Head Neck Surg . 2016;154(1):104-112. https://doi. org/10.1177/0194599815606699 418. Khalili S, Worrall DM, Brooks S, et al. Endoscopy versus imag ing: analysis of surveillance methods in sinonasal malignancy: analysis of surveillance methods in sinonasal malignancy. HeadNeck . 2016;38(8):1229-1233. https://doi.org/10.1002/hed. 24413 419. Zocchi J, Pietrobon G, Campomagnani I, et al. The role of a post therapeutic surveillance program for sinonasal malignan cies: analysis of 417 patients. Head Neck . 2020;42(5):963-973. https://doi.org/10.1002/hed.26069 420. Harvey RJ, Pitzer G, Nissman DB, et al. PET/CT in the assess ment of previously treated skull base malignancies. Head Neck . 2010;32(1):76-84. https://doi.org/10.1002/hed.21147 421. Workman AD, Glicksman JT, Parasher AK, et al. 18 FDG PET/CT in routine surveillance of asymptomatic patients following treatment of sinonasal neoplasms. Otolaryngol Head Neck Surg . 2017;157(6):1068-1074. https://doi.org/10.1177/ 0194599817722959 422. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative pet scan after definitive radiation ther apy? Int J Radiat Oncol Biol Phys . 2004;58(3):694-697. https:// doi.org/10.1016/S0360-3016(03)01625-0 423. Yao M, Smith RB, Graham MM, et al. The role of FDG PET in management of neck metastasis from head-and-neck can cer after definitive radiation treatment. Int J Radiat Oncol Biol Phys . 2005;63(4):991-999. https://doi.org/10.1016/j.ijrobp.2005. 03.066 424. Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope . 2006;116(6):855-858. https://doi.org/10.1097/01. mlg.0000214668.98592.d6 425. Sagardoy T, Fernandez P, Ghafouri A, et al. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squa mous cell carcinoma: 2-year minimum follow-up. Head Neck . 2016;38(Suppl. 1):E1271-1276. https://doi.org/10.1002/ hed.24204 426. Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco